financetom
Business
financetom
/
Business
/
Moderna's influenza vaccine superior to licensed shot in study
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Moderna's influenza vaccine superior to licensed shot in study
Jun 30, 2025 4:37 AM

June 30 (Reuters) - Moderna ( MRNA ) said its

experimental influenza vaccine showed superior efficacy,

compared with a licensed standard-dose seasonal flu shots in

adults aged 50 years and older in a late-stage study.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved